GE Healthcare (NYSE:GE) introduced Mavric SL, a novel magnetic resonance imaging technique intended to more accurately image soft tissue and bone in patients with joint replacements and other implants.
GE Healthcare
GE warns on certain Giraffe infant care systems | MassDevice.com On Call
MASSDEVICE ON CALL — GE Healthcare (NYSE:GE) warned that some of its Giraffe Incubator and OmniBed systems contain a faulty component that may pose a risk to patients.
Consumers Union calls for more stringent oversight of medtech | MassDevice.com On Call
MASSDEVICE ON CALL — Consumer advocacy group Consumers Union submitted a letter to U.S. healthcare regulators, offering more than 11,000 signatures in favor of more stringent oversight of implantable medical devices.
CU urged the FDA to require that all high-risk medical implants undergo clinical testing vie the agency’s premarket approval process, rather than allowing them through via the less-stringent 510(k) pathway, which requires only that a device demonstrate that it’s "substantially equivalent" to a product already cleared by the FDA.
GE Healthcare’s Q1 profits tick up despite slight sales slide
GE Healthcare (NYSE:GE) eked out a small profit increase in the 1st quarter despite essentially flat sales, as its corporate parent reported a 16% profit rise for the 3 months ended March 31.
GE Healthcare posted Q1 profits of $595 million on sales of $4.29 billion, up 1.7% and down 0.3%, respectively, compared with Q1 2012.
GE Healthcare wins FDA OK for new imaging dye, loses $5M jury decision over old dye
Medical products giant GE Healthcare (NYSE:GE) noted wins and losses in its imaging agents this month, landing FDA clearance for its new AdreView cardiac imaging agent after losing a $5 million jury decision over its Omniscan MRI dye.
GE Healthcare inks out an agreement for infant care solutions with GPO HealthTrust
GE Healthcare (NYSE:GE) struck a deal with group purchasing organization HealthTrust for its infant care technologies, including phototherapy, warmers and incubators, which will be available to all of HealthTrust’s member facilities.
‘Burn the data’: Did a company try to hide risks of MRI dye Omniscan?
by Jeff Gerth, ProPublica
In 1994, a scientist studying her company’s new medical imaging dye reached troubling findings. Her boss, she recalls, told her to “burn the data.”
Venezuelan currency shift lowers Johnson & Johnson’s Q1 outlook | Wall Street Beat
Healthcare giant Johnson & Johnson (NYSE:JNJ) expects to incur a charge of about $100 million in its 1st quarter of 2013 due to the negative impact of the Venezuelan government’s decision to devalue its currency, the company reported in a regulatory filing.
Which medical device companies are the best to work for?
Johnson & Johnson (NYSE:JNJ) tops the charts as the best medical device company to work for according to Glassdoor.com, a database of anonymously posted information about salaries, interviews and jobs from current and former medical device industry employees.